A retired physician and his son face up to five and a half years in prison after being charged with operating a family-run pill mill that allegedly distributed highly addictive prescription medications without legitimate medical oversight, in a case that highlights the ongoing challenges of preventing prescription drug abuse and protecting public safety from rogue medical practitioners.
Officials announced Thursday that a doctor and his son have been accused of operating a family-run pill mill in New York, in what authorities describe as a brazen abuse of medical authority to fuel the illegal distribution of prescription drugs. Over a roughly three-month period in the fourth year, the physician allegedly wrote fraudulent prescriptions for highly addictive medications without ever examining patients, while his son found buyers and collected payments as part of the scheme, according to the Drug Enforcement Administration.
Dr. Richard Taubman, a 71-year-old retired physician, and his 33-year-old son, Eric Taubman, surrendered Thursday to investigators with the Nassau County District Attorney's Office following an extensive, multiyear joint investigation. The father and son turned themselves in on Thursday and pleaded not guilty to multiple charges.
The Alleged Scheme
According to the DEA, the father is a retired obstetrician-gynecologist from Great Neck who returned to practice at a non-surgical weight loss center in Islandia, in Suffolk County, in the fourth year. Investigators allege that between April 5 and June 29, 2022, Taubman wrote dozens of prescriptions for controlled substances for multiple individuals without a legitimate medical purpose and outside the course of his practice.
Authorities say the pair distributed a wide range of drugs, including those commonly known as Percocet, Adderall and Xanax. He also submitted the prescriptions electronically from his home in Glen Head to pharmacies across Queens, officials further alleged.
Separately, the son allegedly provided the father with the personal information and drug requests of friends and acquaintances. The investigation also revealed that some individuals allegedly circulated the drugs even further, selling them for profit, trading them for cash and other drugs, or simply using them.
Law Enforcement Response
Numerous reports from pharmacist employees soon flooded the DEA, and the agency said the father's prescription license was stripped roughly one month later. The swift response from pharmacy professionals demonstrates the critical role private sector vigilance plays in identifying suspicious prescription patterns and reporting potential abuse to authorities.
DEA New York Enforcement Division Special Agent in Charge Farhana Islam said, "Their alleged scheme to unlawfully distribute controlled substance prescriptions, placing profits above public health, is not only reckless and dangerous, but unconscionable." She said, "Medical professionals are entrusted with protecting patients' lives, not destroying them by exploiting them to addiction and harm."
Criminal Charges
They are specifically charged with 23 counts of illegally selling or trying to sell drug prescriptions, along with one count of illegally teaming up to carry out this scheme. If convicted, they face up to five and a half years in prison.
The case emerged from an extensive, multiyear joint investigation involving federal and local law enforcement agencies, demonstrating the resources required to build cases against medical professionals who allegedly abuse their prescribing authority. The electronic submission of prescriptions from the physician's home to pharmacies across Queens illustrates how technology, while enabling legitimate telemedicine, can also facilitate illegal distribution when exploited by bad actors.
Why This Matters:
This case underscores the importance of maintaining robust oversight mechanisms and professional accountability within the medical system to prevent abuse of prescribing privileges. The allegations demonstrate how individual bad actors can exploit positions of trust to profit from illegal drug distribution, threatening public health and undermining confidence in legitimate medical practice. The pharmacists who reported suspicious activity exemplify how private sector professionals serve as a critical first line of defense against prescription fraud, suggesting that market-based accountability mechanisms can effectively complement law enforcement efforts. The relatively brief period during which the alleged scheme operated before being detected and shut down reflects the value of existing regulatory frameworks and inter-agency cooperation. However, the case also raises questions about whether current licensing and monitoring systems adequately screen for potential abuse before harm occurs, particularly when retired physicians return to practice in different specialties or settings.